Article
Genomic variation in symptom expression in castrate-resistant prostate cancer.
BMJ supportive & palliative care - 27 Feb 2026
Hardy Janet, Greer Ristan, Foster Karyn, Oliveira Niara, Good Phillip, Vayne-Bossert Petra, Ewing Adam D
Abstract excerpt
OBJECTIVES: Men with castrate-resistant prostate cancer (CRPC) suffer from symptoms related to both their disease and its treatment with marked variation between individuals with respect to symptom expression. This study aimed to determine whether genetic variation in cytokine expression is associated with symptom severity. METHODS: An exploratory prospective, longitudinal consecutive patient cohort study was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
